German genetic-test specialist Qiagen beat forecasts with its third-quarter results and slightly upped its full-year outlook Tuesday. "We're seeing growth across the board," CEO Peer Schatz told CNBC.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.